Comparison Table

Please rotate your device for details

*compared against June 2011 1kGP data release
†The exome content provides focused coverage of exonic regions and does not provide broad genomic coverage outside of coding regions
  Infinium Exome-24 Infinium CoreExome-24 Infinium OmniExpressExome-8 Infinium Omni2.5Exome-8 Infinium Omni5Exome-4
Number of Fixed Markers 244,770 551,839 958,497 2,608,742 4,548,474
Available Custom Markers, max. 50 100,000 30,000 N/A 250,000
Variation Captured (r2>0.8)* MAF >5% MAF >1% MAF >5% MAF >1% MAF >5% MAF >1% MAF >5% MAF >1% MAF >5% MAF >1%
CEU † 0.59 0.46 0.72 0.59 0.83 0.83 0.87 0.87
CHB + JPT † 0.63 0.51 0.73 0.62 0.83 0.83 0.85 0.85
YRI † 0.28 0.18 0.40 0.26 0.65 0.65 0.71 0.71
Spacing (kb)
Mean/Median/90th%		 † 5.3/1.9/14.3 3.0/1.4/7. 6 1.12/0.56/2.63 0.64/0.33/1.50
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see emea.illumina.com/company/legal.html.

© 2026 Illumina, Inc. All rights reserved.